Immunitybio Inc (IBRX)
9.54
-17.40%
Immunitybio Inc (IBRX) is currently trading at $9.54. This represents a loss of 17.4% from the previous session. With a market capitalization of $9.81B, IBRX is a key component of the Health Care sector. Investors looking to trade IBRX should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade IBRX commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Immunitybio Inc (IBRX) shows a bearish trend. Analysts are watching the 12.43 level closely.
Fundamentals
Mkt Cap9.81B
P/E Ratio0.0000
Volume80,841,117
60-Day Technical Chart
Advanced Charting
Need more indicators for IBRX? Use the world's #1 platform.
Open IBRX on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $10
| Metric |
IBRX -17.40% |
ONDS -0.96% |
PATH -1.58% |
NVTS +19.61% |
|---|---|---|---|---|
| Price | $9.54 | $10.30 | $9.94 | $9.88 |
| Mkt Cap | $9.81B | $4.35B | $5.32B | $2.28B |
| - | View → | View → | View → |
Latest Headlines
ImmunityBio: Disconnect Between Clinical Progress And Stock Performance (NASDAQ:IBRX)
Seeking Alpha • Feb 25, 2026
ImmunityBio Stock Is Up 18% This Week: Here’s What Global ANKTIVA Approvals Mean
TIKR.com • Feb 26, 2026
IBRX Stock To Open Week On A High? Chairman Teases Anktiva’s 3-Year Expansion Plans, Hints At Cancer Breakthrough
Stocktwits • Feb 24, 2026
Why ImmunityBio Stock Is Soaring Again Today
The Motley Fool • Feb 23, 2026
Why ImmunityBio (IBRX) Is Up 65.3% After ANKTIVA’s European Approval And New Regional Partnerships
simplywall.st • Feb 24, 2026
● Gemini Agentic AI Analyst Insight for IBRX
Market Education
- How can Retail Traders not lose money to Institutional Traders Jul 15, 2023
- Investors.com Inspired - Top 50 Stocks for 2024 Jun 11, 2023
- 10 rules of money - Follow this and you are set for life Jul 16, 2023
External Research